Currently, TTF-1, detecting in the immunohistochemistry panel, acts as an important prognostic marker for diagnosis of lung adenocarcinoma, which was also proposed by IASLC/ATS/ERS [3, 7–9]. The gene discussed is TTF1; the disease is lung adenocarcinoma.